WAVE2 suppresses mTOR activation to maintain T cell homeostasis and prevent autoimmunity

Author:

Liu Ming123ORCID,Zhang Jinyi123ORCID,Pinder Benjamin D.1245ORCID,Liu Qingquan12,Wang Dingyan1245,Yao Hao1245ORCID,Gao Yubo2ORCID,Toker Aras67,Gao Jimin3,Peterson Alan8910ORCID,Qu Jia3ORCID,Siminovitch Katherine A.12456ORCID

Affiliation:

1. Mount Sinai Hospital, Toronto, Ontario, Canada.

2. Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario, Canada.

3. Wenzhou Medical University, Wenzhou, Zhejiang, China.

4. Toronto General Hospital Research Institute, Toronto, Ontario, Canada.

5. Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

6. Department of Immunology, University of Toronto, Toronto, Ontario, Canada.

7. The Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada.

8. Department of Human Genetics, McGill University, Montreal, Quebec, Canada.

9. Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.

10. Department of Oncology, McGill University, Montreal, Quebec, Canada.

Abstract

WAVE-ing T cell activation off The WAVE regulatory complex (WRC) is a pentameric complex that regulates actin cytoskeleton dynamics. The precise role for the WRC in immunity has not been established, although recent work has implicated WRC components such as HEM1 in certain human immunodeficiencies. Liu et al. characterized mice with a conditional knockout of the WRC constituent WAVE2 (see the Perspective by Hambleton). These mice exhibited progressive severe autoimmune and inflammatory disease associated with the activation and accelerated differentiation of T cells. WAVE2's suppression of T cell activation was not mediated by the T cell receptor but rather by its inhibition of mammalian target of rapamycin (mTOR) binding to RAPTOR and RICTOR. Accordingly, the autoimmune phenotype of these mice could be ameliorated by pharmacological inhibitors of mTOR signaling. Science , this issue p. eaaz4544 ; see also p. 1309

Funder

Canadian Institutes of Health Research

Canada Research Chairs

Sherman Family Chair in Genomic Medicine

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3